Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Nanoscalic silver less toxic than silver sulfadiazine in treating skin infections

March 14, 2008

CRx-191 demonstrates positive phase II results in psoriasis

March 13, 2008

EMEA grants Clinuvel two orphan drug designations for CUV-1647

March 13, 2008

Maruzen imparts novel agents for dermatological disorders in a recent patent

March 13, 2008

Manhattan successfully completes pre-IND meetings with FDA for Altoderm and Altolyn

March 11, 2008

Results reported for phase II Juvista trial in scar revision and breast augmentation

March 5, 2008

Dosing commences in phase I AZX-100 trial in dermal/hypertrophic scarring

March 3, 2008

Immunosyn reports results from proof-of-concept trial of SF-1019 for diabetic ulcers

Feb. 28, 2008

Health Canada approves Welichem Biotech's CTA for phase IIa clinical trial of WBI-1001

Feb. 28, 2008

Recruitment starts for clinical phase III trial of K-301 in seborrheic dermatitis

Feb. 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...